| 0 |
Chemokine Receptor Type 4 Interaction [EPC] |
1 |
0.0007 |
| 1 |
Calcitonin [EPC] |
1 |
0.0003 |
| 2 |
Autologous Cellular Immunotherapy [EPC] |
1 |
0.0002 |
| 3 |
Chloride Channel Activator [EPC] |
1 |
0.0001 |
| 4 |
Provitamin D2 Compound [EPC] |
3 |
0.0001 |
| 5 |
Barbiturate [EPC] |
1 |
0.0001 |
| 6 |
Potassium-sparing Diuretic [EPC] |
1 |
0.0001 |
| 7 |
Tetracycline-class Drug [EPC] |
5 |
0.0001 |
| 8 |
Cystic Fibrosis Transmembrane Conductance Regulator Potentiator [EPC] |
1 |
0.0001 |
| 9 |
Radiographic Contrast Agent [EPC] |
1 |
0.0000 |
| 10 |
Penem Antibacterial [EPC] |
1 |
0.0000 |
| 11 |
Androgen Receptor Inhibitor [EPC] |
2 |
0.0000 |
| 12 |
Opioid Agonist [EPC] |
7 |
0.0000 |
| 13 |
beta3-Adrenergic Agonist [EPC] |
1 |
0.0000 |
| 14 |
Methylxanthine [EPC] |
1 |
0.0000 |
| 15 |
Aromatic Amino Acid [EPC] |
1 |
0.0000 |
| 16 |
Benzodiazepine [EPC] |
9 |
0.0000 |
| 17 |
Central Nervous System Stimulant [EPC] |
1 |
0.0000 |
| 18 |
Nonsteroidal Anti-inflammatory Drug [EPC] |
13 |
0.0000 |
| 19 |
Sodium-Glucose Cotransporter 2 Inhibitor [EPC] |
1 |
0.0000 |
| 20 |
P2Y12 Platelet Inhibitor [EPC] |
1 |
0.0000 |
| 21 |
Angiotensin Converting Enzyme Inhibitor [EPC] |
1 |
0.0000 |
| 22 |
Vitamin C [EPC] |
3 |
0.0000 |
| 23 |
Vitamin D [EPC] |
2 |
0.0000 |
| 24 |
Vitamin B12 [EPC] |
2 |
0.0000 |
| 25 |
Estrogen [EPC] |
1 |
0.0000 |
| 26 |
RANK Ligand Inhibitor [EPC] |
1 |
0.0000 |
| 27 |
Expectorant [EPC] |
1 |
0.0000 |
| 28 |
Thiazide Diuretic [EPC] |
1 |
0.0000 |
| 29 |
Atypical Antipsychotic [EPC] |
2 |
0.0000 |
| 30 |
Platelet Aggregation Inhibitor [EPC] |
2 |
0.0000 |
| 31 |
Angiotensin 2 Receptor Blocker [EPC] |
1 |
0.0000 |
| 32 |
Folate Analog Metabolic Inhibitor [EPC] |
1 |
0.0000 |
| 33 |
GLP-1 Receptor Agonist [EPC] |
1 |
0.0000 |
| 34 |
Loop Diuretic [EPC] |
1 |
0.0000 |
| 35 |
Thalidomide Analog [EPC] |
1 |
0.0000 |
| 36 |
Kinase Inhibitor [EPC] |
1 |
0.0000 |
| 37 |
Proton Pump Inhibitor [EPC] |
1 |
0.0000 |
| 38 |
Corticosteroid [EPC] |
1 |
0.0000 |